Why Cross-Regional Partnerships Will Define the Future of ADCs in South Korea?
For ADC developers in South Korea, one strategic priority has become unmistakably clear: building partnerships with global pharmaceutical and biotech companies.
These collaborations are enabling Korean innovators to advance their ADC pipelines into clinical development and scalable GMP manufacturing, without compromising on speed, quality, or cost efficiency. As next-generation ADCs become more complex, global partnerships are now fundamental across the entire ADC lifecycle:
- Early discovery and target validation
- Payload, linker, and conjugation optimisation
- IND-enabling studies and regulatory alignment
- Large-scale manufacturing
- Commercialisation and global market entry
In short: cross-regional collaboration is accelerating Korea’s rise as an ADC development hub.
Industry News Round Up: Explore the Partnership Momentum Happening in Korea
Over the past year, the pace of collaboration deals has rapidly increased, reinforcing Korea’s position as one of the fastest-growing ADC ecosystems in Asia.
Some of the most notable developments include:
- Lotte Biologics, Kanaph Therapeutics, and Axcelead Discovery Partners sign tripartite MoU to develop ADC toolbox
- LigaChem inks two ADC deals with CSPC Novarock
- AbTis and Chemexpress form strategic toolbox partnership
- Novelty Nobility joins JLABS Korea
- Pinotbio to lead 22bn Won ADC localization project backed by the Korean government
- Samsung Bio and Celltrion announce major expansion into ADC production
- Samsung Biologics and LigaChem extend collaboration
- Samjin Pharmaceutical and APTIBIO collaborate on ADC development
- LigaChem Bio and Ono Pharma ink $700m
- Daiichi Sankyo Korea launches 5 new ADC therapies
Why Do the Recent Headlines Matter for ADC Developers?
Partnership activity is now accelerating across discovery, clinical development, CMC, and commercial strategy. This collaborative momentum is creating:
- Faster IND timelines
- Access to global expertise, platforms, and payload technologies
- Better quality and scalability in manufacturing
- Increased investor confidence
- More opportunities for Korean companies to enter global markets
Partnerships have become the key driver of ADC innovation and differentiation in Korea.
Where is the ADC Industry Heading in 2026?
To analyze these trends and many more redefining ADCs in 2026, Asian-based industry experts will meet at the 5th World ADC Summit South Korea to discuss:
- R&D / discovery
- Clinical development
- Manufacturing and CMC
- Partnerships and business development
With eight hours of structured and informal networking, this is where partnership conversations start, deals accelerate, and the region’s next-generation ADC strategies take shape.
If you’re looking to…
- Secure new partnerships
- Accelerate IND approvals
- Advance first‑ or best‑in‑class ADC candidates
- Expand into ADC manufacturing
- Enter the Korean or wider APAC market
…this summit is the room where the conversations happen. Download the full event guide to learn more.
Explore the Agenda
Hear the latest ADC technology innovations taking place within South Korea and gain exclusive insights on the progress in ADC development globally.
Partner With Us
Position yourself alongside other leading solution providers to ensure your company is the go-to service providers for Korean ADC leaders.
Join Biopharma Experts
Be part of the hottest conversations with like-minded scientists, C-level executives, heads, managers, VPs, and more across discovery, clinical and CMC functions.